IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
-4.43%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$307M
AUM Growth
-$43.3M
(-12%)
Cap. Flow
+$19.6M
Cap. Flow
% of AUM
6.4%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
181
New
26
Increased
23
Reduced
31
Closed
32
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$14M |
| 2 |
Akero Therapeutics
AKRO
|
+$9.92M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$8.62M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$8.53M |
| 5 |
Vaxcyte
PCVX
|
+$7.55M |
Top Sells
| 1 |
Spyre Therapeutics
SYRE
|
+$6.57M |
| 2 |
Tarsus Pharmaceuticals
TARS
|
+$6.3M |
| 3 |
Avalo Therapeutics
AVTX
|
+$6.17M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$4.91M |
| 5 |
BridgeBio Pharma
BBIO
|
+$4.32M |
Sector Composition
| 1 | Healthcare | 95.44% |
| 2 | Consumer Staples | 0% |
| 3 | Financials | 0% |
